Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
970 DKK | -0.34% | +0.41% | +38.95% |
16/07 | Novo Nordisk's Main Owner Leads $100 Million Financing of Biotech Firm Asceneuron | DJ |
16/07 | Novo owner backs Swiss biotech Asceneuron in $100 million round | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.95% | 631B | |
+61.53% | 856B | |
-3.66% | 359B | |
+15.06% | 325B | |
+9.18% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.67% | 177B | |
+2.47% | 165B | |
+2.41% | 126B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Novo Nordisk To Acquire US-based Forma Therapeutics For $1 Billion